Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,230,370
+$1,375,285 QoQ
Shares Held
961,501
+1.8% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,316,203,980 across 189 Biotechnology names. DSGN ranks #79 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,000,428 | $65,938,209 |
All Filings in DSGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,230,370 | 961,501 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,855,085 | 944,039 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,613,721 | 612,712 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,620,299 | 777,537 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,492,378 | 645,694 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||